Previous Article | Next Article 
Infection and Immunity, September 2000, p. 5234-5240, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Induction of Interleukin-4 (IL-4) by Legionella
pneumophila Infection in BALB/c Mice and Regulation of Tumor
Necrosis Factor Alpha, IL-6, and IL-1
Catherine
Newton,*
Shannon
McHugh,
Ray
Widen,
Noriya
Nakachi,
Thomas
Klein, and
Herman
Friedman
Department of Medical Microbiology and
Immunology, University of South Florida College of Medicine, Tampa,
Florida 33612
Received 29 December 1999/Returned for modification 18 February
2000/Accepted 14 June 2000
 |
ABSTRACT |
Infection of BALB/c mice with a sublethal concentration of
Legionella pneumophila causes an acute disease that is
resolved by innate immune responses. The infection also initiates the
development of adaptive Th1 responses that protect the mice from
challenge infections. To study the early responses, cytokines induced
during the first 24 h after infection were examined. In the serum,
interleukin-12 (IL-12) was detectable by 3 h and peaked at 10 h, while gamma interferon was discernible by 5 h and peaked at
8 h. Similar patterns were observed in ex vivo cultures of
splenocytes. A transient IL-4 response was also detected by 3 h
postinfection in ex vivo cultures. BALB/c IL-4-deficient mice were more
susceptible to L. pneumophila infection than were wild-type
mice. The infection induced higher serum levels of acute-phase
cytokines (tumor necrosis factor alpha [TNF-
], IL-1
, and IL-6),
and reducing TNF-
levels with antibodies protected the mice from
death. Moreover, the addition of IL-4 to L. pneumophila-infected macrophage cultures suppressed the
production of these cytokines. Thus, the lack of IL-4 in the deficient
mice resulted in unchecked TNF-
production, which appeared to cause
the mortality. Monocyte chemoattractant protein-1 (MCP-1), a chemokine
that is induced by IL-4 during Listeria monocytogenes infection, was detected at between 2 and 30 h after infection. However, MCP-1 did not appear to be induced by IL-4 or to be required for the TNF-
regulation by IL-4. The data suggest that the early increase in IL-4 serves to regulate the mobilization of acute phase
cytokines and thus controls the potential harmful effects of these cytokines.
 |
INTRODUCTION |
Legionella pneumophila
causes Legionnaires' disease and Pontiac Fever (13). The
initial phase of disease in humans (11) is characterized by
symptoms that correspond to acute-phase cytokine mobilization
(21). In BALB/c mice, infection results in an acute disease
wherein the animals either survive or die during the first 60 h of
infection (22, 28). Survival depends on the induction of
innate immune mechanisms, including macrophage activation by gamma
interferon (IFN-
) (1, 17, 26, 36), protection by tumor
necrosis factor alpha (TNF-
) (2, 3, 25, 35, 37), and the
production of interleukin-6 (IL-6) and IL-1 (21, 22, 44).
Although the mobilization of these cytokines is generally protective
(2, 35), they can also induce enhanced mortality if their
levels in blood and tissue become excessive (22). The mortality is similar to septic shock (5, 16), and the mice can be rescued with anti-TNF-
or anti-IL-6 antibodies
(22). It appears, therefore, that the mobilization of
acute-phase cytokines following L. pneumophila infection can
be either protective or detrimental depending upon the extent of
cytokine mobilization as well as other unknown factors.
L. pneumophila is a gram-negative, facultative intracellular
bacterium, which primarily infects macrophages and monocytes (18). As with other intracellular pathogens, protective
adaptive immunity depends on Th1 immunity and the associated cytokines, IFN-
and IL-12 (19). These cytokines appear early during
the course of infection and promote the development of Th1 cells
(19, 31, 41). IL-4, on the other hand, is reported to be
detrimental to the survival of animals, especially BALB/c mice, because
of its role in induction of Th2 cells (15, 31). However,
IL-4 was detected in mice within 3 h of infection with
Listeria monocytogenes (6, 12, 15) and
Mycobacterium tuberculosis (6, 7), and the
transient IL-4 did not interfere with development of Th1 responses.
More recently, IL-4 has been demonstrated to induce monocyte
chemoattractant protein-1 (MCP-1) production during innate immunity to
L. monocytogenes (6, 12, 20), and this induction of MCP-1 mediates the recruitment of monocytes, macrophages, and activated T cells (14). In the present study, we report that L. pneumophila infection also induces an IL-4 response along
with MCP-1, IL-12, IFN-
, TNF-
, IL-1
, and IL-6. Studies with
IL-4-deficient mice suggest that IL-4 regulates the levels of TNF-
,
IL-1
, and IL-6, independently of MCP-1.
 |
MATERIALS AND METHODS |
Mice.
Female BALB/c and BALB/c-IL-4tm2Nnt
(29) mice, at 7 to 8 weeks of age (Jackson Laboratories, Bar
Harbor, Maine), were used in these studies. They were housed and cared
for in the University of South Florida Health Sciences Center animal
facility, which is fully accredited by the American Association for
Accreditation of Laboratory Animal Care.
Bacteria.
L. pneumophila M124, a virulent serogroup 1 isolate from Tampa General Hospital (Tampa, Fla.), was grown on
buffered charcoal-yeast extract agar (BCYE; Difco, Detroit, Mich.) for
48 h from a passage 3 stock maintained at
80°C. The bacteria
were suspended in pyrogen-free saline, and the concentration was
adjusted spectrophotometrically.
Mouse infections.
For mortality studies, mice were infected
intravenously in the tail vein with 1 × 106 to
20 × 106 L. pneumophila. Mice died within
60 h of infection, and surviving mice were monitored for an
additional 2 to 3 weeks. In other experiments, infected mice were
CO2 asphyxiated at various times postinfection, and blood
and spleens were harvested. Sera were processed and analyzed for
cytokines. Splenocyte suspensions were prepared with a Stomacher 80 homogenizer (Tekmar, Cincinnati, Ohio) and processed for ex vivo
cultures or RNA extraction.
Ex vivo cultures.
Prepared splenocytes (5 × 106 cells/ml) were cultured without additional stimulation
in 24-well plates (Costar, Cambridge, Mass.) in RPMI 1640 medium
(Sigma, St. Louis, Mo.) supplemented with 10% fetal calf serum
(HyClone, Logan, Utah) and penicillin-streptomycin. Supernatants were
collected either at 3 h of culture for IL-4 or at 24 h for
IFN-
and IL-12. Cytokine levels were measured by enzyme-linked
immunosorbent assay (ELISA).
Neutralization of cytokines.
BALB/c-IL-4tm2Nnt
mice were injected intravenously in the tail veins with 0.1 ml of
neutralizing anti-cytokine antibodies at 15 and 24 h
postinfection. The antibodies used were rat anti-IL-6 (10 µg/mouse;
PharMingen, San Diego, Calif.), rabbit anti-TNF-
polyclonal serum
(0.1 ml/mouse; Genzyme, Cambridge, Mass.), hamster anti-IL-1
(10 µg/mouse; Genzyme), and the appropriate isotype control antibodies.
Macrophage infections.
Mice were injected intraperitoneally
with 3 ml of thioglycolate medium 4 days prior to macrophages being
collected by peritoneal lavage. Adherence-purified macrophages
(106 cells/ml) were infected with L. pneumophila
(10:1) for 30 min, washed, and cultured for 24 h. Alternatively,
macrophages were exposed to killed bacteria (100:1) for 24 h.
Recombinant IL-4 (PharMingen), at concentrations of between 100 and
5,000 pg/ml, was added to the cultures after infection or at the same
time as the killed bacteria. In selected cultures, macrophages were lysed with 0.1% saponin (Sigma), and lysates were diluted and plated
on BCYE agar for 72 h. CFU counts were determined by standard plate counting.
ELISAs.
Cytokine levels of IFN-
, IL-4, IL-6, and IL-12
p40-p70 were determined by sandwich ELISAs using antibody pairs from
PharMingen according to protocols previously described (27).
The antibody pairs for the IL-12 p40-p70 ELISA capture and detects p40
protein and thus detects both p70 and p40 proteins. Some serum samples were also analyzed using OptEIA Mouse IL-12 (p70) kit (PharMingen). MCP-1 was measured according to the above-described protocols using an
anti-MCP-1 capture antibody (10 µg/ml), a biotinylated detection
anti-MCP-1 antibody (2 µg/ml), and recombinant MCP-1 standard
(starting at 25 ng/ml; PharMingen). TNF-
and IL-1
assays were
performed using DuoSet assay kits (Genzyme). The
3,3',5,5'-tetramethylbenzidine [TMB] Liquid Substrate System (Sigma)
was added for 5 to 30 min, and the horseradish peroxidase reaction was
stopped with 1 N sulfuric acid. The plates were read at 450 nm on an
Emax Microplate Reader (Molecular Devices, Mento Park, Calif.). Units
were calculated from a standard curve run with each plate. The low-end
sensitivities for each ELISA were as follows: IFN-
(200 pg/ml), IL-4
(20 pg/ml), IL-6 (200 pg/ml), IL-12p40/p70 (250 pg/ml), MCP-1 (500 pg/ml), TNF-
(50 pg/ml), IL-1
(20 pg/ml), and IL-12 p70 (250 pg/ml).
RT-PCR.
RNA was extracted by standard protocols with 1 ml of
TriReagent (Sigma) per 2 × 107 splenocytes collected
from individual mice. Reverse transcription (RT) of total RNA was
performed with avian myeloblastosis virus reverse transcriptase
(Promega, San Diego, Calif.), and the RT product was PCR amplified as
previously described (46). The IL-4 primer pairs
(5'-CATCGGCATTTTGAACGAGGTCA and
5'-CTTATCGATGAATCAGGCATCG) were specifically designed for
mRNA. The control gene product,
-actin, was amplified using the
following primer pair: 5'-ATGGATGACGATATCGCT and
5'-ATGAGGTAGTCTGTCAGGT. The PCR was performed in a
Minicycler (MJ Research, Watertown, Miss.) at a 60°C annealing
temperature for 30 cycles for IL-4 and for 25 cycles for
-actin. The
products were visualized in a 2% agarose gel with ethidium bromide.
Statistical analysis.
Data were analyzed by one-way analysis
of variance with Dunnett's test for comparing individuals using
SigmaStat (Jandel Scientific, San Rafael, Calif.).
 |
RESULTS |
L. pneumophila infection induces early IL-12 and
IFN-
responses.
To study cytokines produced early during innate
immunity, mice were infected with 7 × 106 L. pneumophila and at various times sera were analyzed for IL-12 p40-p70 and IFN-
. As shown in Fig. 1A,
IL-12 p40-p70 began to rise in the serum as early as 3 h
postinfection and peaked at 10 h postinfection. Since IL-12
p40-p70 ELISA detected both p40 and p70 proteins, some serum samples
were also analyzed with a p70-specific ELISA (OptEIA) for comparison.
At 5 h postinfection, there was more p40 being produced because
the levels detected by p40-p70 ELISA were higher than that of the p70
ELISA, e.g., 13.4 ± 2.8 versus 7.2 ± 1.4 ng/ml. However, at
8 h postinfection, the difference between the two ELISA assays was
very slight (13.3 ± 1.06 versus 12.7 ± 1.8 ng/ml). Similar
results were obtained with an IL-12 bioassay, which measured the
induction of IFN-
by IL-12 (45). At 5 h, more p40
protein was detected (8.7 ± 1 versus 3.7 ± 0.8 ng/ml), and
at 12 h the levels were equivalent (8.9 ± 0.5 versus
8.0 ± 0.4 ng/ml). Thus, IL-12 detected in the serum by the IL-12
p40-p70 ELISA during the peak times appears to be primarily the
bioactive p70 protein. IFN-
was also measured in the serum, and the
kinetics were similar to those of IL-12, with peak production occurring
at 8 h postinfection (Fig. 1B). In addition to assaying sera for
cytokines, splenocytes from these mice were cultured ex vivo without
additional stimulation, and supernatants were collected at 24 h.
The ex vivo cytokine patterns were similar to serum, although spleen
production appeared to precede the cytokines in the serum, with IL-12
p40-p70 increasing within 1 h of infection (Fig. 1C) and IFN-
increasing within 3 h (Fig. 1D). This suggested that the spleen
was at least one source of the serum cytokine response. Cytokine
levels, in all cases, returned to or near baseline levels by 24 h
(Fig. 1).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 1.
L. pneumophila infection induces IL-12 and
IFN- during the first 24 h after infection. Mice were infected
with 7 × 106 bacteria and, at the indicated times
after infection, blood and spleens were collected. (A and B) Serum
cytokine levels. (C and D) Splenocyte ex vivo production. For panels C
and D, the splenocytes were cultured without any additional stimulation
for 24 h, and the supernatants were analyzed. Both sera and
supernatants were measured by sandwich ELISAs. Each bar is the
mean ± the standard error of the mean (SEM) of three to five
experiments for a total of 6 to 16 mice.
|
|
Early IL-4 levels were detected in L. pneumophila-infected mice.
Mice were infected as described
above, and splenocytes were collected at 3, 5, and 24 h
postinfection. The cells (5 × 106/ml) were cultured
without additional stimulation, and supernatants were harvested at
3 h for ELISA. As shown in Fig. 2A,
IL-4 protein reached maximum production levels in the cells at 3 and
5 h postinfection and decreased to near baseline by 24 h.
IL-12 p40-p70 and IFN-
were not detected in these 3-h cultures but
were detected at 24 h. We were unable to detect IL-4 in any of the
serum samples. Therefore, in order to support the observation of
splenic production of IL-4, we analyzed splenocytes for IL-4 mRNA by
RT-PCR. Mice were infected and splenocytes were removed and analyzed at
1, 2, and 3 h postinfection. IL-4 mRNA expression was increased by 1 h after infection relative to
-actin mRNA (Fig. 2B),
supporting the conclusion that the spleen mobilizes IL-4 early after
infection.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
L. pneumophila infection induces IL-4
production. Mice were infected with 7 × 106 bacteria
and, at the times indicated, spleens were collected. (A) Splenocytes
were cultured without additional stimulation for 3 h, supernatants
were collected, and IL-4 levels were determined by ELISA. Each bar is
the mean ± the SEM of data from three experiments. (B)
Splenocytes were lysed with TriReagent, RNA was extracted, and RT-PCR
was performed. The bands were visualized with ethidium bromide in a 2%
agarose gel. Each lane contains an upper IL-4 band and a lower
-actin band. Each lane is represents an individual mouse, with N1
and N2 representing normal (uninfected) mice, and lanes 1 to 6 showing
results for L. pneumophila infected mice at the indicated
times postinfection. The gel is a representative experiment. *,
P < 0.05.
|
|
Mice deficient in IL-4 are more susceptible to L. pneumophila infection.
To examine possible functions for the
induction of the early IL-4 protein, BALB/c and
BALB/c-IL-4tm2Nnt mice were infected with various
concentrations of L. pneumophila, and the mortality was
determined. As shown in Table 1,
IL-4-deficient mice were more susceptible to L. pneumophila
infection than were the wild-type mice. At a concentration at which all
of the competent mice survived, 100% (six of six) of the
IL-4-deficient mice died. This increased susceptibility suggested that
IL-4 functioned to protect the mice. Because deaths occurred in both
groups of mice at between 30 and 60 h postinfection, it was
concluded that the effect of IL-4 occurred during innate immune
responses.
Elevated acute-phase cytokines were detected in the IL-4-deficient
mice and anti-TNF-
antibodies were protective.
We have
previously observed that mortality in L. pneumophila-infected BALB/c mice is due to increased mobilization
of acute-phase cytokines because the mice were protected by
pretreatment with antibodies to TNF-
or IL-6 (22). To
determine if IL-4-deficient mice produced higher levels of TNF-
,
IL-1
, and IL-6, mice were infected with 5 × 106
L. pneumophila, a concentration that kills 75% of the
deficient mice (see Table 1). Sera were collected at 24 h
postinfection, and cytokine levels were determined by ELISAs. Compared
competent mice, the BALB/c-IL-4tm2Nnt mice had
significantly higher levels of all three cytokines, especially TNF-
and IL-6 (Fig. 3). Therefore, to examine
the effect of antibody neutralization, BALB/c-IL-4tm2Nnt
mice were infected with 7 × 106 bacteria and, at 15 and 24 h postinfection, were injected with either antibodies to
IL-6, IL-1
, or TNF-
or to isotype controls. When the infected
mice were treated with isotype controls, three of three mice succumbed
to the infection. In contrast, the anti-TNF-
antibodies protected
three of three mice from death. Anti-IL-1
and anti-IL-6 antibodies
had no effect in this experiment; however, these levels of antibodies
had previously been shown to provide partial protection
(22). The data suggested that IL-4 downregulated acute-phase
cytokine mobilization and thus reduced the mortality associated with
excessive levels of the cytokines, especially TNF-
.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
L. pneumophila infection induces higher serum
levels of acute-phase cytokines in IL-4-deficient mice. Normal BALB/c
and BALB/c-IL-4 tm2Nnt mice were infected with 5 × 106 bacteria, and sera were collected at 24 h
postinfection. Cytokine levels were determined by ELISA. Data are the
means ± the SEMs for three experiments. *, P < 0.05.
|
|
IL-4 reduced acute-phase cytokine production in infected macrophage
cultures.
To examine the possible downregulation directly,
thioglycolate-elicited macrophages were treated with either living or
killed L. pneumophila in the presence or absence of IL-4.
Supernatants from 24-h cultures were analyzed by ELISA for IL-1
,
TNF-
, and IL-6. As shown in Fig. 4A,
IL-4 at concentrations of as low as 100 pg/ml caused a significant
decrease in IL-1
production. A suppressive effect on TNF-
production was also observed, but at a 1,000-pg/ml concentration (Fig.
4B). Very little IL-6 was produced in response to live bacteria;
however, treatment with killed bacteria increased the IL-6 production,
and this response was attenuated by IL-4 treatment (Fig. 4C). The
observed decreases in the cytokine levels were not due to fewer
bacteria in the IL-4-treated cultures. In fact, the addition of IL-4
(5,000 pg/ml) significantly increased the number of bacteria detected
in the cultures (P < 0.05; Fig. 4D). The concentration
of IL-4 needed to suppress TNF-
and IL-6 was fivefold greater than
the concentration detected in ex vivo splenocyte cultures (see Fig. 2).
However, the IL-4 concentration in these cultures was produced in a
1-ml volume by only 1/20th of the spleen. Extrapolation to an intact
animal makes it more likely that the tissue levels were much higher
than the 200 pg/ml seen in the ex vivo cultures.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
IL-4 treatment of L. pneumophila-stimulated
macrophage cultures decreases the production of acute-phase cytokines.
Thioglycolate-elicited peritoneal macrophages were infected with
L. pneumophila (10:1) or stimulated with killed L. pneumophila (100:1). IL-4 (100 to 5,000 pg/ml) was added after
bacterial infection or with the killed L. pneumophila.
Supernatants were collected at 24 h and assayed by ELISAs for
IL-1 (A), TNF- (B), and IL-6 (C). (D) In addition, the CFU of
bacteria were determined on lysates of cells by the plate count method.
Data are the means ± the SEMs for three experiments. *,
P < 0.05.
|
|
IL-4-deficient and competent mice have elevated MCP-1 levels
following infection.
MCP-1 has been demonstrated to be induced by
IL-4 in listeriosis (6, 12, 20). Additionally, MCP-1 has
been shown to reduce lipopolysaccharide-induced mortality
(47), suggesting that IL-4 could be controlling IL-1
,
TNF-
, and IL-6 by inducing MCP-1. To examine this, BALB/c mice were
infected with L. pneumophila, and sera were collected at
several time points between 1 and 48 h. Elevated serum levels of
MCP-1 were detected beginning 2 h postinfection and continued past
30 h, with the level peaking at ca. 8 h (Fig.
5A). To examine the effect of IL-4 on
MCP-1, sera were collected from BALB/c-IL-4tm2Nnt mice at
8 h postinfection, and the MCP-1 level was measured. The deficient
mice had an equivalent level of MCP-1 compared to competent mice (Fig.
5B), indicating that IL-4 was not required for MCP-1 induction.
Furthermore, since both groups of mice had equivalent levels of MCP-1
and since only the deficient mice had elevated levels of acute-phase
cytokines, it appears unlikely that the chemokine was directly involved
in the downregulation of the cytokines.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Serum MCP-1 levels are elevated following L. pneumophila infection in BALB/c and BALB/c-IL-4tm2Nnt
mice. Mice were infected either with 7 × 106 (BALB/c)
or with 5 × 106 (BALB/c-IL-4tm2Nnt)
bacteria per mouse, and sera collected at the indicated times after
infection. (A) Time kinetics for serum MCP-1 in BALB/c mice. (B) Serum
level of MCP-1 at 8 h postinfection in BALB/c and
BALB/c-IL-4tm2Nnt mice. Data are the means ± the
SEMs for three experiments.
|
|
 |
DISCUSSION |
Much of what is known about the development of innate
and cell-mediated (Th1) immunity to intracellular
pathogens comes from studies with L. monocytogenes
(34, 42). Protective immunity to L. monocytogenes
involves both innate immunity, which limits the growth of the bacteria,
and cell-mediated immunity, with its antigen-specific T cells, which
clear the infection (8, 42). If an adequate cell-mediated
immunity does not develop, the animals died within several days of
infection. In contrast, L. pneumophila infection of BALB/c
mice causes death within 60 h of infection, suggesting that innate
responses are vital for survival of the animals. However, while Th1
responses do not appear to be important for resolution of the infection
during the initial infection stage, they are crucial for survival of
subsequent challenge (28). Therefore, our L. pneumophila infection model appears to be appropriate for studying
the innate responses to intracellular bacteria as well as the
corresponding development of Th1 responses.
In the present study, we examined cytokine production during the
first 24 h after infection to define the early cytokine
environment. Elevated levels of IL-12 p40-p70 and IFN-
were observed
in the serum within 3 to 5 h postinfection. These increases most
likely promote the subsequent development of Th1 immunity that we have previously observed (28). This idea would agree with
observations of others regarding intracellular pathogen infections
(19, 33). An early IL-4 response was also detected.
Moreover, IL-4-deficient mice were found to be more susceptible
to the L. pneumophila infection, suggesting that the IL-4
had a protective role. Such a role was supported by additional findings
that implied that IL-4 attenuated the mobilization of acute-phase
cytokines during the early immune response. The IL-4-deficient mice had
elevated levels of TNF-
, IL-1
, and IL-6, and IL-4
treatment of L. pneumophila-infected macrophage cultures
suppressed their production. Furthermore, treating deficient mice
with anti-TNF-
antibodies protects the animals from L. pneumophila infection.
IL-4 has been shown to induce the production of MCP-1 in an L. monocytogenes infection model (12, 20). This did not
occur following L. pneumophila infection, as evidenced by
the finding that the mobilization of MCP-1 was equivalent in both
IL-4-competent and IL-4-deficient mice. Moreover, the presence of MCP-1
in IL-4-deficient mice did not appear to effect the elevated levels of
TNF-
, IL-1
, and IL-6, indicating that MCP-1 was not involved in
the IL-4-mediated downregulation of these cytokines. The intracellular
life cycles of L. pneumophila and L. monocytogenes are quite different. L. pneumophila,
after entering the cell, avoids phagosome-lysosome fusion and the
corresponding acidification and replicates within specialized
endosomes, while L. monocytogenes lyses the vacuoles and
survives in the cytoplasm (19, 33). Therefore, it is
possible that these intracellular differences account for the
observed variations in cytokine production and function. Additionally, L. pneumophila and L. monocytogenes are
gram-negative and gram-positive bacteria, respectively. Different
Toll-like receptors, which are involved in TNF-
induction, have
recently been shown to distinguish between the two types of bacteria
(43). Therefore, while both are facultative intracellular
bacteria, L. pneumophila and L. monocytogenes
differ in their interactions with immune cells, and these differences
could account for the disparities observed here.
An inverse correlation between IL-4 and TNF-
production, however,
has been reported in IFN-
-receptor-deficient mice after L. monocytogenes infection (39). As in our study, IL-4
production attenuated the TNF-
response. However, unlike our study,
the lowered TNF-
response resulted in a more severe infection. As in
our findings, several groups have observed increased susceptibility in
IL-4-deficient mice to other pathogens, e.g., Toxoplasma
gondii (32, 38) and Schistosoma mansoni
(4). Moreover, Brunet et al. concluded that the increased
susceptibility to S. mansoni was due to a failure to
regulate TNF-
production, leading to acute cachexia during the early
stages of schistosomiasis (4). A regulatory role for IL-4
has also been proposed by Falcone et al. in an experimental allergic
encephalomyelitis (EAE) model. In this study, IL-4-deficient BALB/c
mice developed a more severe form of EAE due to an uncontrolled
proinflammatory cytokine response, which included TNF-
(10). Therefore, IL-4 has an ameliorating effect in several
diseases, in addition to the one observed in our study.
It is also of interest to note that the IL-4 response did not appear to
be required for Th1 development to L. pneumophila. IL-4-deficient mice developed a robust splenic, antigen-specific IFN-
production at day 5 postinfection and survived a later
challenge infection (data not shown). Others have also reported that
IL-4-deficient mice develop Th1 responses to intracellular pathogens
(23, 30, 32).
It is not clear at this time how IL-4 is regulating the production of
TNF-
and other cytokines. It is possible that IL-4 is functioning
with the aid of other Th2 cytokines such as IL-10. However, we were
unable to detect any IL-10 in our system. Additionally, IL-4 has been
demonstrated by several groups to downregulate IL-6, IL-1, and TNF-
protein and/or gene expression (9, 24, 40). Thus, IL-4 may
be functioning to control these cytokines at a transcriptional level,
and this is currently under investigation.
In summary, our data demonstrate that L. pneumophila
infection of BALB/c mice rapidly induces IL-12 and IFN-
, as well as an early, transient IL-4 response. Infections in IL-4-deficient mice
suggest that IL-4 plays a regulatory function during the innate immune
responses. In contrast to the proposed role for IL-4 in a
Listeria infection, IL-4 produced during L. pneumophila infections appears to be involved in regulating
acute-phase cytokines, especially TNF-
.
 |
ACKNOWLEDGMENT |
This work was supported by Public Health Service grant
AI45169-01 from the National Institute of Allergy and Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology and Immunology, University of South Florida
College of Medicine, 12901 Bruce B. Downs Blvd., Tampa, FL 33612. Phone: (813) 974-4017. Fax: (813) 974-4151. E-mail:
cnewton{at}hsc.usf.edu.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Bhardwaj, N.,
T. W. Nash, and M. A. Horwitz.
1986.
Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.
J. Immunol.
137:2662-2669[Abstract].
|
| 2.
|
Blanchard, D. K.,
J. Y. Djeu,
T. W. Klein,
H. Friedman, and W. E. D. Stewart.
1988.
Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function.
J. Leukoc. Biol.
43:429-435[Abstract].
|
| 3.
|
Brieland, J. K.,
D. G. Remick,
M. L. LeGendre,
N. C. Engleberg, and J. C. Fantone.
1998.
In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12.
Infect. Immun.
66:65-69[Abstract/Free Full Text].
|
| 4.
|
Brunet, L. R.,
F. D. Finkelman,
A. W. Cheever,
M. A. Kopf, and E. J. Pearce.
1997.
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis.
J. Immunol.
159:777-785[Abstract].
|
| 5.
|
Cerami, A., and B. Beutler.
1988.
The role of cachectin/TNF in endotoxic shock and cachexia.
Immunol. Today
9:28-31[CrossRef][Medline].
|
| 6.
|
Collins, H.,
I. E. Flesch,
M. Emoto, and S. H. Kaufmann.
1998.
Interleukin-4 production in response to infection with intracellular bacteria.
Adv. Exp. Med. Biol.
452:75-83[Medline].
|
| 7.
|
Collins, H. L.,
U. E. Schaible, and S. H. Kaufmann.
1998.
Early IL-4 induction in bone marrow lymphoid precursor cells by mycobacterial lipoarabinomannan.
J. Immunol.
161:5546-5554[Abstract/Free Full Text].
|
| 8.
|
Conlan, J. W.
1999.
Early host-pathogen interactions in the liver and spleen during systemic murine listeriosis: an overview.
Immunobiology
201:178-187[Medline].
|
| 9.
|
Essner, R.,
K. Rhoades,
W. H. McBride,
D. L. Morton, and J. S. Economou.
1989.
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.
J. Immunol.
142:3857-3861[Abstract].
|
| 10.
|
Falcone, M.,
A. J. Rajan,
B. R. Bloom, and C. F. Brosnan.
1998.
A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
J. Immunol.
160:4822-4830[Abstract/Free Full Text].
|
| 11.
|
Finegold, S. M.
1988.
Legionnaires' disease still with us.
N. Engl. J. Med.
318:571-573[Medline].
|
| 12.
|
Flesch, I. E.,
A. Wandersee, and S. H. Kaufmann.
1997.
IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis.
J. Immunol.
159:7-10[Abstract].
|
| 13.
|
Fraser, D. W.,
T. R. Tsai,
W. Orenstein,
W. E. Parkin,
H. J. Beecham,
R. G. Sharrar,
J. Harris,
G. F. Mallison,
S. M. Martin,
J. E. McDade,
C. C. Shepard, and P. S. Brachman.
1977.
Legionnaires' disease: description of an epidemic of pneumonia.
N. Engl. J. Med.
297:1189-1197[Abstract].
|
| 14.
|
Gu, L.,
S. C. Tseng, and B. J. Rollins.
1999.
Monocyte chemoattractant protein-1.
Chem. Immunol.
72:7-29[Medline].
|
| 15.
|
Haak-Frendscho, M.,
J. F. Brown,
Y. Iizawa,
R. D. Wagner, and C. J. Czuprynski.
1992.
Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection.
J. Immunol.
148:3978-3985[Abstract].
|
| 16.
|
Hack, C. E.,
L. A. Aarden, and L. G. Thijs.
1997.
Role of cytokines in sepsis.
Adv. Immunol.
66:101-195[Medline].
|
| 17.
|
Heath, L.,
C. Chrisp,
G. Huffnagle,
M. LeGendre,
Y. Osawa,
M. Hurley,
C. Engleberg,
J. Fantone, and J. Brieland.
1996.
Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts.
Infect. Immun.
64:5151-5160[Abstract].
|
| 18.
|
Horwitz, M. A., and S. C. Silverstein.
1980.
Legionnaires' disease bacterium (Legionella pneumophila) multiplies intracellularly in human monocytes.
J. Clin. Investig.
66:441-450.
|
| 19.
|
Kaufmann, S. H.
1993.
Immunity to intracellular bacteria.
Annu. Rev. Immunol.
11:129-163[CrossRef][Medline].
|
| 20.
|
Kaufmann, S. H.,
M. Emoto,
G. Szalay,
J. Barsig, and I. E. Flesch.
1997.
Interleukin-4 and listeriosis.
Immunol. Rev.
158:95-105[CrossRef][Medline].
|
| 21.
|
Klein, T.,
C. Newton,
Y. Yamamoto, and H. Friedman.
1999.
Immune responses to Legionella, p. 149-166.
In
L. Paradise, H. Friedman, and M. Bendinelli (ed.), Opportunistic intracellular bacteria and immunity. Plenum Press, Inc., New York, N.Y.
|
| 22.
|
Klein, T. W.,
C. Newton,
R. Widen, and H. Friedman.
1993.
Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.
J. Pharmacol. Exp. Ther.
267:635-640[Abstract/Free Full Text].
|
| 23.
|
Kropf, P.,
R. Etges,
L. Schopf,
C. Chung,
J. Sypek, and I. Muller.
1997.
Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
J. Immunol.
159:3434-3443[Abstract].
|
| 24.
|
Lee, J. D.,
K. Rhoades, and J. S. Economou.
1995.
Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and -6, and interferon-gamma.
Immunol. Cell. Biol.
73:57-61[Medline].
|
| 25.
|
Matsiota-Bernard, P.,
C. Lefebre,
M. Sedqui,
P. Cornillet, and M. Guenounou.
1993.
Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes.
Infect. Immun.
61:4980-4983[Abstract/Free Full Text].
|
| 26.
|
Nash, T. W.,
D. M. Libby, and M. A. Horwitz.
1988.
IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.
J. Immunol.
140:3978-3981[Abstract].
|
| 27.
|
Newton, C.,
T. Klein, and H. Friedman.
1998.
The role of macrophages in THC-induced alteration of the cytokine network.
Adv. Exp. Med. Biol.
437:207-214[Medline].
|
| 28.
|
Newton, C. A.,
T. W. Klein, and H. Friedman.
1994.
Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection.
Infect. Immun.
62:4015-4020[Abstract/Free Full Text].
|
| 29.
|
Noben-Trauth, N.,
G. Kohler,
K. Burki, and B. Ledermann.
1996.
Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line.
Transgenic Res.
5:487-491[CrossRef][Medline].
|
| 30.
|
Noben-Trauth, N.,
P. Kropf, and I. Muller.
1996.
Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
Science
271:987-990[Abstract].
|
| 31.
|
Reiner, S. L., and R. M. Locksley.
1995.
The regulation of immunity to Leishmania major.
Annu. Rev. Immunol.
13:151-177[CrossRef][Medline].
|
| 32.
|
Roberts, C. W.,
D. J. Ferguson,
H. Jebbari,
A. Satoskar,
H. Bluethmann, and J. Alexander.
1996.
Different roles for interleukin-4 during the course of Toxoplasma gondii infection.
Infect. Immun.
64:897-904[Abstract].
|
| 33.
|
Schaible, U. E.,
H. L. Collins, and S. H. Kaufmann.
1999.
Confrontation between intracellular bacteria and the immune system.
Adv. Immunol.
71:267-377[Medline].
|
| 34.
|
Shen, H.,
C. M. Tato, and X. Fan.
1998.
Listeria monocytogenes as a probe to study cell-mediated immunity.
Curr. Opin. Immunol.
10:450-458[CrossRef][Medline].
|
| 35.
|
Skerrett, S. J.,
G. J. Bagby,
R. A. Schmidt, and S. Nelson.
1997.
Antibody-mediated depletion of tumor necrosis factor-alpha impairs pulmonary host defenses to Legionella pneumophila.
J. Infect. Dis.
176:1019-1028[Medline].
|
| 36.
|
Skerrett, S. J., and T. R. Martin.
1992.
Recombinant murine interferon-gamma reversibly activates rat alveolar macrophages to kill Legionella pneumophila.
J. Infect. Dis.
166:1354-1361[Medline].
|
| 37.
|
Skerrett, S. J., and T. R. Martin.
1996.
Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.
Infect. Immun.
64:3236-3243[Abstract].
|
| 38.
|
Suzuki, Y.,
Q. Yang,
S. Yang,
N. Nguyen,
S. Lim,
O. Liesenfeld,
T. Kojima, and J. S. Remington.
1996.
IL-4 is protective against development of toxoplasmic encephalitis.
J. Immunol.
157:2564-2569[Abstract].
|
| 39.
|
Szalay, G.,
C. H. Ladel,
C. Blum, and S. H. Kaufmann.
1996.
IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice.
J. Immunol.
157:4746-4750[Abstract].
|
| 40.
|
Takeshita, S.,
J. R. Gage,
T. Kishimoto,
D. L. Vredevoe, and O. Martinez-Maza.
1996.
Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines.
J. Immunol.
156:2591-2598[Abstract].
|
| 41.
|
Trinchieri, G.
1995.
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
Annu. Rev. Immunol.
13:251-276[Medline].
|
| 42.
|
Unanue, E. R.
1997.
Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response.
Immunol. Rev.
158:11-25[CrossRef][Medline].
|
| 43.
|
Underhill, D. M.,
A. Ozinsky,
A. M. Hajjar,
A. Stevens,
C. B. Wilson,
M. Bassetti, and A. Aderem.
1999.
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
Nature
401:811-815[CrossRef][Medline].
|
| 44.
|
Widen, R. H.,
T. W. Klein,
C. A. Newton, and H. Friedman.
1989.
Induction of interleukin 1 by Legionella pneumophila in murine peritoneal macrophage cultures.
Proc. Soc. Exp. Biol. Med.
191:304-308[CrossRef][Medline].
|
| 45.
|
Wysocka, M.,
M. Kubin,
L. Q. Vieira,
L. Ozmen,
G. Garotta,
P. Scott, and G. Trinchieri.
1995.
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
Eur. J. Immunol.
25:672-676[Medline].
|
| 46.
|
Yamamoto, Y.,
C. Retzlaff,
P. He,
T. W. Klein, and H. Friedman.
1995.
Quantitative reverse transcription-PCR analysis of Legionella pneumophila-induced cytokine mRNA in different macrophage populations by high-performance liquid chromatography.
Clin. Diagn. Lab. Immunol.
2:18-24[Abstract].
|
| 47.
|
Zisman, D. A.,
S. L. Kunkel,
R. M. Strieter,
W. C. Tsai,
K. Bucknell,
J. Wilkowski, and T. J. Standiford.
1997.
MCP-1 protects mice in lethal endotoxemia.
J. Clin. Investig.
99:2832-2836[Medline].
|
Infection and Immunity, September 2000, p. 5234-5240, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Newton, C. A., Perkins, I., Widen, R. H., Friedman, H., Klein, T. W.
(2007). Role of Toll-Like Receptor 9 in Legionella pneumophila-Induced Interleukin-12 p40 Production in Bone Marrow-Derived Dendritic Cells and Macrophages from Permissive and Nonpermissive Mice. Infect. Immun.
75: 146-151
[Abstract]
[Full Text]
-
Sporri, R., Joller, N., Albers, U., Hilbi, H., Oxenius, A.
(2006). MyD88-Dependent IFN-{gamma} Production by NK Cells Is Key for Control of Legionella pneumophila Infection. J. Immunol.
176: 6162-6171
[Abstract]
[Full Text]
-
Newton, C. A., Lu, T., Nazian, S. J., Perkins, I., Friedman, H., Klein, T. W.
(2004). The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. J. Leukoc. Biol.
76: 854-861
[Abstract]
[Full Text]
-
Nara, C., Tateda, K., Matsumoto, T., Ohara, A., Miyazaki, S., Standiford, T. J., Yamaguchi, K.
(2004). Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-{alpha}. J Med Microbiol
53: 727-733
[Abstract]
[Full Text]
-
Kikuchi, T., Kobayashi, T., Gomi, K., Suzuki, T., Tokue, Y., Watanabe, A., Nukiwa, T.
(2004). Dendritic Cells Pulsed with Live and Dead Legionella pneumophila Elicit Distinct Immune Responses. J. Immunol.
172: 1727-1734
[Abstract]
[Full Text]
-
SHINOZAWA, Y., MATSUMOTO, T., UCHIDA, K., TSUJIMOTO, S., IWAKURA, Y., YAMAGUCHI, K.
(2002). Role of interferon-gamma in inflammatory responses in murine respiratory infection with Legionella pneumophila. J Med Microbiol
51: 225-230
[Abstract]
[Full Text]
-
Khan, A. Q., Shen, Y., Wu, Z.-Q., Wynn, T. A., Snapper, C. M.
(2002). Endogenous Pro- and Anti-Inflammatory Cytokines Differentially Regulate an In Vivo Humoral Response to Streptococcus pneumoniae. Infect. Immun.
70: 749-761
[Abstract]
[Full Text]